Search results for "Diabetes management"

showing 10 items of 15 documents

Professional continuous glucose monitoring in subjects with type 1 diabetes: retrospective hypoglycemia detection.

2013

Background: An important task in diabetes management is detection of hypoglycemia. Professional continuous glucose monitoring (CGM), which produces a glucose reading every 5 min, is a powerful tool for retrospective identification of unrecognized hypoglycemia. Unfortunately, CGM devices tend to be inaccurate, especially in the hypoglycemic range, which limits their applicability for hypoglycemia detection. The objective of this study was to develop an automated pattern recognition algorithm to detect hypoglycemic events in retrospective, professional CGM. Method: Continuous glucose monitoring and plasma glucose (PG) readings were obtained from 17 data sets of 10 type 1 diabetes patients und…

AdultBlood GlucoseMalemedicine.medical_specialtyendocrine system diseasesEndocrinology Diabetes and MetabolismBiomedical EngineeringBioengineeringHypoglycemiaSensitivity and SpecificityAutomationDiabetes managementBlood Glucose Self-MonitoringDiabetes mellitusInternal MedicineMedicineHumansIntensive care medicineGlycemicMonitoring PhysiologicRetrospective StudiesType 1 diabetesbusiness.industryContinuous glucose monitoringBlood Glucose Self-Monitoringnutritional and metabolic diseasesRetrospective cohort studyMiddle Agedmedicine.diseaseHypoglycemiaDiabetes Mellitus Type 1Original ArticlebusinessAlgorithmsJournal of diabetes science and technology
researchProduct

A cross-sectional survey among patients and prescribers on insulin dosing irregularities and impact of mild (self-treated) hypoglycemia episodes in S…

2014

In Spain, data suggest that 13.8% of adults have diabetes. Two important aspects in diabetes management are mild hypoglycemic episodes and poor treatment adherence. This study assesses the impact of missed insulin doses and prevalence of mistimed and reduced insulin doses and mild hypoglycemia in patients with type 2 diabetes treated with basal insulin analogues in Spain, and compares the data collected to pooled data from 8 other European countries (OECs).GAPP2 was an international, online, cross-sectional study of diabetic patients aged ≥40 years treated with long-acting insulin analogues and their healthcare professionals. Patients and healthcare professionals were recruited from online …

AdultMalemedicine.medical_specialtyCross-sectional studyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentHealth PersonnelType 2 diabetesHypoglycemiaSeverity of Illness IndexMedication AdherenceEndocrinologyQuality of lifeDiabetes managementInternal medicineDiabetes mellitusSurveys and QuestionnairesmedicineHumansHypoglycemic AgentsInsulinDosingAgedAged 80 and overbusiness.industryInsulinMiddle Agedmedicine.diseaseHypoglycemiaSurgeryEuropeSelf CareCross-Sectional StudiesDiabetes Mellitus Type 2SpainFemalebusinessEndocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion
researchProduct

Are older patients with diabetes still being overtreated in French long-term care homes?

2020

Abstract Background Diabetes management has not been evaluated in French nursing homes (NHs) for 10 years. Objectives The present study aimed to compare the management of diabetes with guidelines in older patients living in NHs. Design Observational, retrospective and multicentre study carried out in 13 NH in the Cote d’Or region of France. Settings and subjects Between January and June 2018, all NH residents older than 65 years and known to have diabetes (n = 148) were included. Methods Epidemiological, clinical and biological data and diabetes characteristics were collected from the medical records. Results The average glycated haemoglobin (HbA1C) was 7.2 ± 1.2%. In total, 51% of patients…

Blood GlucoseAgingmedicine.medical_specialty030209 endocrinology & metabolismHypoglycemia03 medical and health sciences0302 clinical medicineDiabetes managementInternal medicineDiabetes mellitusEpidemiologymedicineHumansHypoglycemic Agents030212 general & internal medicineAgedRetrospective StudiesBlood glucose monitoringmedicine.diagnostic_testbusiness.industryBlood Glucose Self-MonitoringMedical recordGeneral Medicinemedicine.diseaseLong-Term CareLong-term careDiabetes Mellitus Type 2Observational studyFranceGeriatrics and GerontologybusinessAge and Ageing
researchProduct

A Worldwide Perspective on COVID-19 and Diabetes Management in 22,820 Children from the SWEET Project: Diabetic Ketoacidosis Rates Increase and Glyce…

2021

Aims: To investigate the short-term effects of the first wave of COVID-19 on clinical parameters in children with type 1 diabetes (T1D) from 82 worldwide centers participating in the Better Control in Pediatric and Adolescent DiabeteS: Working to CrEate CEnTers of Reference (SWEET) registry. Materials and Methods: Aggregated data per person with T1D £21 years of age were compared between May/June 2020 (first wave), August/September 2020 (after wave), and the same periods in 2019. Hierarchic linear and logistic regression models were applied. Models were adjusted for gender, age-, and diabetes duration-groups. To distinguish the added burden of the COVID-19 pandemic, the centers were divided…

Blood GlucoseMale2019-20 coronavirus outbreakPediatricsmedicine.medical_specialtyHbA1cAdolescentCoronavirus disease 2019 (COVID-19)Diabetic ketoacidosisEndocrinology Diabetes and MetabolismSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)030209 endocrinology & metabolismGlycemic Control03 medical and health sciences0302 clinical medicineEndocrinologyDiabetes managementDiabetic ketoacidosisDiabetes mellitusHumansMedicine030212 general & internal medicineChildPandemicsChildrenGlycemicGlycated HemoglobinType 1 diabetesbusiness.industryCGMBlood Glucose Self-MonitoringCOVID-19CSIIBMI.medicine.diseaseMedical Laboratory TechnologyDiabetes Mellitus Type 1Type 1 diabetesFemalebusinessDiabetes Technology & Therapeutics
researchProduct

PsychDT Working Group

2015

Background: Diabetes technology is a cornerstone of diabetes management in the 21st century, with advances in available devices over recent years playing a central role in the way that health care has progressed. Psychosocial interventions have been shown to have a positive impact on glycemic control, reduce psychological distress and reduce costs of health care. Addressing and improving psychosocial outcomes that complement biomedical improvements and looking to the future are crucial to enhance patient acceptance of artificial pancreas (AP) systems. Methods: To achieve closer collaboration and comparability across different AP research trials, a working group was established. Results: Exi…

Blood GlucosePancreas ArtificialGerontologyParisEndocrinology Diabetes and MetabolismDecision MakingBiomedical EngineeringBioengineeringArtificial pancreasAutomationQuality of life (healthcare)Diabetes managementDiabetes mellitusHealth careInternal MedicineHumansPsychologyMedicineInterdisciplinary communicationClinical Trials as Topicbusiness.industryManagement scienceProceedings of Meetings/ConferencesCornerstoneCongresses as Topicmedicine.diseaseDiabetes Mellitus Type 1Quality of LifeInterdisciplinary CommunicationbusinessPsychosocialJournal of Diabetes Science and Technology
researchProduct

2020

Background Evidence suggests that mobile health app use is beneficial for the prevention and management of type 2 diabetes (T2D) and its associated complications; however, population-based research on specific determinants of health app use in people with and without T2D is scarce. Objective This cross-sectional study aimed to provide population-based evidence on rates and determinants of health app use among adults with and without T2D, thereby covering a prevention perspective and a diabetes management perspective, respectively. Methods The study population included 2327 adults without a known diabetes diagnosis and 1149 adults with known T2D from a nationwide telephone survey in Germany…

Diabetes risk020205 medical informaticsEndocrinology Diabetes and MetabolismPopulationBiomedical Engineering030209 endocrinology & metabolismHealth Informatics02 engineering and technologyOverweight03 medical and health sciences0302 clinical medicineHealth Information ManagementDiabetes management0202 electrical engineering electronic engineering information engineeringMedicineSocial determinants of healtheducationeducation.field_of_studybusiness.industryOdds ratiomedicine.diseaseObesityComputer Science ApplicationsHealth promotionmedicine.symptombusinessDemographyJMIR Diabetes
researchProduct

Gamification and Behavior Change Techniques in Diabetes Self-Management Apps

2019

Background: Diabetes management apps may have positive effects on diabetes self-management. It remains unclear, however, which app features are particularly effective and encourage sustained app usage. Behavior change techniques (BCTs) and gamification are promising approaches to improve user engagement. However, little is known about the frequency BCTs and gamification techniques (GTs) are actually used. This app review aims to provide an overview of BCTs and GTs in current diabetes management apps. Methods: Google’s Play Store was searched for applications using a broad search strategy (keyword: “diabetes”). We limited our research to freely available apps. A total of 56 apps matched the …

Gerontology020205 medical informaticsEndocrinology Diabetes and MetabolismBiomedical EngineeringBioengineeringDiabetes self managementReview Article02 engineering and technologyDiabetes Complications03 medical and health sciences0302 clinical medicineBehavior TherapyDiabetes managementDiabetes mellitusmental disordersDiabetes Mellitus0202 electrical engineering electronic engineering information engineeringInternal MedicinemedicineHumans030212 general & internal medicinemHealthbusiness.industrySelf-ManagementBehavior change methodsmedicine.diseaseMobile ApplicationsVideo GamesbusinessCell PhoneJournal of Diabetes Science and Technology
researchProduct

Pragmatic Diabetes Management in Nursing Homes: Individual Care Plan

2013

Although the management of diabetes as a simple entity has been extensively developed, there is a dearth of evidence in elderly, frail patients with multiple comorbidities and polymedication. This population represents a large proportion of the residents of nursing homes (NHs). As a multidisciplinary group of French experts (geriatricians, endocrinologists, diabetologists, and general practitioners) with practical experience in this area, which is growing in magnitude throughout the world, we convened to compile pragmatic, simple advice on the management of elderly, frail diabetic patients. Given demands on NH personnel (manager, medical coordinator, nurses, and, at the front line of care p…

Inservice TrainingFrail ElderlyPopulationComorbidityDiseaseHypoglycemiaCare provisionPatient Care PlanningNursingRisk FactorsDiabetes managementDiabetes mellitusDiabetes MellitusmedicineHumansMedical prescriptioneducationGeneral NursingAgededucation.field_of_studybusiness.industryHealth PolicyDisease ManagementGeneral Medicinemedicine.diseaseNursing HomesMalnutritionGeriatricsPolypharmacyMedical emergencyGeriatrics and GerontologybusinessJournal of the American Medical Directors Association
researchProduct

Patients with type 1 diabetes transition from pediatric to adult care in Poland—an example from Silesia

2014

Transition from pediatric to the adult care system is an important issue for diabetes management. The objective was to evaluate the transition of young adults with type 1 diabetes (T1DM) from pediatric to adult diabetes care. Questionnaires were sent to all T1DM patients (166), who left pediatric diabetes care in Katowice, Poland (2003–2007). Analyzed parameters included: date of first visit and visit frequency in adult care, HbA1c (mean and final at pediatric care, HbA1c_M and F respectively, reported in questionnaire – HbA1c_Q), and history of acute complications. 132(82.5 %) responses were received. 96(73 %) patients undertook their first visit at adult clinic ≤3 months after finishing p…

Insulin pumpPediatricsmedicine.medical_specialtyType 1 diabetesHbA1cbusiness.industryEndocrinology Diabetes and MetabolismAdult caremedicine.diseaseChildhoodAdolescenceType 1 diabetesDiabetes managementDiabetes mellitusTransitionInternal MedicinemedicineIn patientYoung adultbusinessGlycemicInternational Journal of Diabetes in Developing Countries
researchProduct

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-…

2017

Background Dapagliflozin is a sodium-glucose cotransporter-2 inhibitor approved for the treatment of type 2 diabetes. We aimed to assess the efficacy and safety of dapagliflozin as an add-on to adjustable insulin in patients with inadequately controlled type 1 diabetes. Methods DEPICT-1 was a double-blind, randomised, parallel-controlled, three-arm, phase 3, multicentre study done at 143 sites in 17 countries. Eligible patients were aged 18–75 years and had inadequately controlled type 1 diabetes (HbA1c between ≥7·7% and ≤11·0% [≥61·0 mmol/mol and ≤97·0 mmol/mol]) and had been prescribed insulin for at least 12 months before enrolment. After an 8 week lead-in period to optimise diabetes man…

MaleGlycated Hemoglobin AEndocrinology Diabetes and MetabolismType 2 diabetes030204 cardiovascular system & hematologySettore MED/13 - Endocrinologialaw.inventionchemistry.chemical_compound0302 clinical medicineEndocrinologydiabetes dapaglifozinGlucosidesRandomized controlled triallawInsulin03.02. Klinikai orvostanDapagliflozinMiddle AgedDiabetes and MetabolismTreatment OutcomeCombinationDrug Therapy CombinationFemaleType 1Adultmedicine.medical_specialtyDiabetic ketoacidosis030209 endocrinology & metabolismPlacebo03 medical and health sciencesDrug TherapyDiabetes managementDiabetes mellitusInternal medicineDiabetes MellitusInternal MedicinemedicineHumansHypoglycemic AgentsBenzhydryl CompoundsAdult; Benzhydryl Compounds; Body Weight; Diabetes Mellitus Type 1; Drug Therapy Combination; Female; Glucosides; Glycated Hemoglobin A; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Treatment OutcomeAdult; Benzhydryl Compounds; Body Weight; Diabetes Mellitus Type 1; Drug Therapy Combination; Female; Glucosides; Glycated Hemoglobin A; Humans; Hypoglycemia; Hypoglycemic Agents; Insulin; Male; Middle Aged; Treatment Outcome; Internal Medicine; Endocrinology Diabetes and Metabolism; EndocrinologyGlycated HemoglobinType 1 diabetesbusiness.industryBody Weightmedicine.diseaseHypoglycemiaSurgeryDiabetes Mellitus Type 1chemistrybusinessThe Lancet Diabetes & Endocrinology
researchProduct